DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $71,252,796 | -1.8% | 285,182 | -1.8% | 0.97% | +9.4% |
Q1 2024 | $72,542,191 | +3.6% | 290,494 | -4.0% | 0.88% | +1.1% |
Q4 2023 | $70,003,271 | -8.3% | 302,599 | -1.7% | 0.88% | -16.0% |
Q3 2023 | $76,346,007 | +1.5% | 307,723 | -1.8% | 1.04% | +9.9% |
Q2 2023 | $75,222,543 | -5.8% | 313,427 | -1.1% | 0.95% | -15.4% |
Q1 2023 | $79,864,439 | +93385.2% | 316,872 | -1.6% | 1.12% | -12.7% |
Q4 2022 | $85,430 | -99.9% | 321,868 | -2.0% | 1.28% | +1.8% |
Q3 2022 | $84,846,000 | -47.7% | 328,490 | -48.7% | 1.26% | +2.8% |
Q2 2022 | $162,338,000 | +62.5% | 640,338 | +88.0% | 1.23% | +8.6% |
Q1 2022 | $99,885,000 | -14.7% | 340,521 | -4.3% | 1.13% | -2.5% |
Q4 2021 | $117,085,000 | +5.3% | 355,870 | -2.6% | 1.16% | +3.9% |
Q3 2021 | $111,208,000 | +14.4% | 365,286 | +0.8% | 1.12% | +13.0% |
Q2 2021 | $97,229,000 | +23.1% | 362,306 | +3.2% | 0.99% | +9.7% |
Q1 2021 | $79,005,000 | +4.8% | 351,007 | +3.5% | 0.90% | +8.0% |
Q4 2020 | $75,372,000 | +6.2% | 339,299 | +3.0% | 0.83% | -15.9% |
Q3 2020 | $70,948,000 | +25.4% | 329,486 | +3.0% | 0.99% | +11.5% |
Q2 2020 | $56,557,000 | +33.5% | 319,837 | +4.5% | 0.89% | +0.1% |
Q1 2020 | $42,373,000 | -9.3% | 306,139 | +0.6% | 0.89% | +5.7% |
Q4 2019 | $46,722,000 | +52.9% | 304,418 | +43.8% | 0.84% | +44.9% |
Q3 2019 | $30,565,000 | +2.7% | 211,623 | +1.7% | 0.58% | +2.8% |
Q2 2019 | $29,748,000 | – | 208,141 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |